Koninklijke DSM Ownership

KDSKFDelisted Stock  USD 25.30  0.00  0.00%   
Koninklijke DSM NV maintains a total of 172.97 Million outstanding shares. Over half of Koninklijke DSM's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Koninklijke DSM in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Koninklijke DSM, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Koninklijke Pink Sheet Ownership Analysis

About 57.0% of the company shares are owned by institutional investors. The book value of Koninklijke DSM was now reported as 56.38. The company has Price/Earnings To Growth (PEG) ratio of 2.88. Koninklijke DSM NV recorded earning per share (EPS) of 6.71. The entity last dividend was issued on the 4th of August 2022. The firm had 2:1 split on the 5th of September 2005. Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. KONINKLIJKE DSM operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 21760 people.The quote for Koninklijke DSM NV is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Koninklijke DSM NV contact the company at 31 45 578 8111 or learn more at https://www.dsm.com.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Koninklijke Pink Sheet

If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world